Delivery Order SPE2DB20D3103-SPE2DB23FN4H9
- Not listed
- This federal contract award, valued at $7,466.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with an ultimate completion date of January 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,635.58 for the supply of JANUMET 50-1,000 MG TABLET 180S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 27, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,212.44 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award, valued at $5,424.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S, with a completion date of February 23, 2024. This is a firm fixed-price delivery order contract, and it was awarded without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $13,502.98, is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The award has an ultimate completion date of May 4, 2023, and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
- This federal contract award, valued at $7,703.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 4560937411 JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product. The award has an ultimate completion date of May 16, 2023 and utilizes a Firm Fixed Price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $22,745.97 delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $75,487.29, is for the delivery of Janumet 50-1,000 mg tablets. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,595.16 Firm Fixed Price Delivery Order is for the supply of Janumet 50-1,000 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,530.50 for JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on March 10, 2022, with a completion date of March 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN4H9Delivery Order
This federal contract award, valued at $65,989.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of JANUMET 50-1,000 MG TABLET 60S, a pharmaceutical product. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.0k | 5/17/23 |